Zydus gains final USFDA approval for Valbenazine Capsules EP News Bureau Aug 9, 2024 Valbenazine Capsules had annual sales of $ 1,993.6 million in the United States (IQVIA MAT June 2024)
Lupin gets tentative US FDA approval for Valbenazine capsules EP News Bureau Mar 27, 2023 Valbenazine is indicated for the treatment of tardive dyskinesia (uncontrollable movement of face, tongue, or other body parts)
